<

 
Data updated 2025-05-13 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date11745672.3 (espacenet)  (Federated)  (European Patent Register), 20110809
Patent/reg. no. and dateDK/EP 2603523, 20160127
Publication date20130619
Priority no. and dateUS 373026 P, 20100812
EP pub. no. and date EP 2603523 20130619
Effective date
Applicant/ownerEli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.P81600348DK00E
InventorLU, Jirong, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US,
TANG, Ying, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US,
DEMATTOS, Ronald Bradley, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 39/395 (2006.01) , A61P 25/28 (2006.01) , C07K 16/18 (2006.01) , G01N 33/577 (2006.01) 
TitleANTI-N3pGlu-AMYLOIDBETAPEPTIDANTISTOFFER OG ANVENDELSER DERAF
Int. application no.US2011046994
Int. publication no.WO2012021469
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact